SWOG clinical trial number
SWOG-8755

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma

Closed
Phase
Published
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma
Activated
06/15/1988
Closed
01/01/1990

Publication Information Expand/Collapse

1992

High incidence of coagulopathy in phase II studies of recombinant tumor necrosis factor (rTNF) in advanced pancreatic and gastric cancers.

FM Muggia;TD Brown;PJ Goodman;EM Hersh;TR Fleming;L Leichman Anti-Cancer Drugs 3(3):211-217

1991

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A Southwest Oncology Group study.

TD Brown;PJ Goodman;T Fleming;JS Macdonald;EM Hersh;TJ Braun Journal of Immunotherapy 10:376-378

1990

Recombinant tumor necrosis factor (rTNF) intolerance in pancreatic and gastric cancers: A Southwest Oncology Group study.

FM Muggia;T Brown;P Goodman;L Leichman;J Macdonald;EM Hersh AACR 31:185(#1102)